OBJECTIVES: We explored a potential association between nasal polyps (NPs) and polymorphism at loci for human leukocyte antigen (HLA) DR and HLA-DQ. METHODS: Polymorphism at loci HLA-DR and HLA-DQ were examined in 30 patients with NPs and in 81 healthy subjects by use of the polymerase chain reaction-sequence specific primer method. RESULTS: HLA-DR16, HLA-DQ8, and HLA-DQ9 were found to be significantly associated with NPs. HLA-DR16, HLA-DQ8, and HLA-DQ9 specificities were found at higher frequencies in patients with NPs than in control subjects (5% versus 0.62%, RR = 8.9, p = .03; 10% versus 2.47%, RR = 4.81, p = .01; and 20% versus 6.18%, RR = 4.73%, p = .001; respectively). In contrast, HLA-DQ7 was found at lower frequencies in patients with NPs than in controls (10% versus 20.37%, RR = 0.36, p = .04). CONCLUSIONS: We conclude that HLA-DR16, HLA-DQ8, and HLA-DQ9 represent potential susceptibility determinants and that HLA-DQ7 might confer resistance in nasal polyps.
OBJECTIVES: We explored a potential association between nasal polyps (NPs) and polymorphism at loci for human leukocyte antigen (HLA) DR and HLA-DQ. METHODS: Polymorphism at loci HLA-DR and HLA-DQ were examined in 30 patients with NPs and in 81 healthy subjects by use of the polymerase chain reaction-sequence specific primer method. RESULTS: HLA-DR16, HLA-DQ8, and HLA-DQ9 were found to be significantly associated with NPs. HLA-DR16, HLA-DQ8, and HLA-DQ9 specificities were found at higher frequencies in patients with NPs than in control subjects (5% versus 0.62%, RR = 8.9, p = .03; 10% versus 2.47%, RR = 4.81, p = .01; and 20% versus 6.18%, RR = 4.73%, p = .001; respectively). In contrast, HLA-DQ7 was found at lower frequencies in patients with NPs than in controls (10% versus 20.37%, RR = 0.36, p = .04). CONCLUSIONS: We conclude that HLA-DR16, HLA-DQ8, and HLA-DQ9 represent potential susceptibility determinants and that HLA-DQ7 might confer resistance in nasal polyps.
Authors: Yohan Bossé; François Bacot; Alexandre Montpetit; Johan Rung; Hui-Qi Qu; James C Engert; Constantin Polychronakos; Thomas J Hudson; Philippe Froguel; Robert Sladek; Martin Desrosiers Journal: Hum Genet Date: 2009-01-29 Impact factor: 4.132
Authors: Joy Hsu; Pedro C Avila; Robert C Kern; M Geoffrey Hayes; Robert P Schleimer; Jayant M Pinto Journal: J Allergy Clin Immunol Date: 2013-04 Impact factor: 10.793
Authors: Ignacio Dávila; Carmen Rondón; Ana Navarro; Encarnación Antón; Carlos Colás; María Teresa Dordal; María Dolores Ibáñez; Beatriz Fernández-Parra; Magdalena Lluch-Bernal; Víctor Matheu; Javier Montoro; María Cesárea Sánchez; Antonio Valero Journal: Am J Rhinol Allergy Date: 2012 Sep-Oct Impact factor: 2.467
Authors: Monique C Arnold; Seerat Poonia; Lauren Colquitt; Cailu Lin; Alyssa Civantos; Michael Kohanski; Nithin D Adappa; James N Palmer; Danielle R Reed; Noam A Cohen Journal: Int Forum Allergy Rhinol Date: 2022-01-25 Impact factor: 5.426
Authors: Claus Bachert; Ruby Pawankar; Luo Zhang; Chaweewan Bunnag; Wytske J Fokkens; Daniel L Hamilos; Orathai Jirapongsananuruk; Robert Kern; Eli O Meltzer; Joaquim Mullol; Robert Naclerio; Renata Pilan; Chae-Seo Rhee; Harumi Suzaki; Richard Voegels; Michael Blaiss Journal: World Allergy Organ J Date: 2014-10-27 Impact factor: 4.084